FDA Approved Weight Loss Drugs

SEMAGLUTIDE

FDA-Approved Once-Weekly Weight Loss Prescription
Initial Program Start-up Cost $299.00, without bi-weekly syringe cost (Valued at $600)

First month program includes

  • Consultation with Dr. Heydari, MD, FACS
  • Bi-weekly office visits to instruct use and dose escalation
  • Weigh-in and blood pressure monitored
  • Therapeutic lifestyle diet support & body composition

Semaglutide is a modified version of GLP-1, which has been developed to last for a long time in the body, and therefore only needs to be injected once per week.

  • NO OTHER DRUG has come close to producing this level of weight loss
  • FDA-Approved Semaglutide/GLP-1 RA for Chronic Weight Management as adjunct to reduced calorie diet and increased physical activity
  • Certain adults qualify with BMI of 30 or more; BMI of 27 with one weight-related co-morbid condition such as hypertension, type-2 diabetes, or hyperlipidemia
  • Impressive efficacy and safety data
  • 15%-18% Weight loss, with some patients achieving 20% weight loss

Semaglutide Medications include: OzempicTM and MoujurnoTM


WEGOVYTM

FDA-Approved Once-Weekly Weight Loss Prescription
Initial Program Start-up Cost $299.00, without bi-weekly syringe cost (Valued at $495) Plus the cost of your prescriptions.

First month program includes

  • Consultation with Dr. Heydari, MD, FACS
  • Prescription for WegovyTM /Semaglutide injection 2.4mg
  • Weekly office visits to instruct use of “pen” and dose escalation
  • Weigh-in and blood pressure monitored
  • Therapeutic lifestyle diet support & body composition
  • Get to Know WegovyTM Starter Kit and personal web portal

Consecutive months include

  • 2-Week follow up office visit
  • Weigh-in and blood pressure monitored
  • Body composition as needed
  • New prescription

WegovyTM is the first weight loss medication since 2014 called “A major breakthrough and a game changer”

  • NO OTHER DRUG has come close to producing this level of weight loss
  • FDA-Approved WegovyTM Semaglutide/GLP-1 RA for Chronic Weight Management as adjunct to reduced calorie diet and increased physical activity
  • Certain adults qualify with BMI of 30 or more; BMI of 27 with one weight-related co-morbid condition such as hypertension, type-2 diabetes, or hyperlipidemia
  • Impressive efficacy and safety data
  • Prescription price may be as low as $25 for up to six months
  • 15%-18% Weight loss, with some patients achieving 20% weight loss

PHENTERMINE 37.5 mg

Phentermine works by stimulating the hypothalamus gland and affecting certain neurotransmitters to decrease appetite.

The hypothalamus is the region of the brain that controls the autonomic nervous system, regulating sleep cycles, body temperature, and appetite.

Phentermine should NOT be used as a substitute for proper diet or exercise. For maximum effects, you will receive a personalized reduced-calorie diet plan to lose the weight, and knowledge for long-term lifestyle strategies to prevent the lost weight from returning.

With the Phentermine Monthly Program, you will be given a four week supply of Oral capsules of phentermine 37.5 mg Hydrochloride (HCL) for weight loss. Phentermine is in the Sympathomimetic family of appetite suppressants to be used for short-term management of obesity. You will also get your initial office visit and, two weeks later, a follow-up office visit included in your program.

This powerful appetite suppressant will give you the control you need along with a lifestyle diet plan to reach your weight loss goal.


QsymiaQsymia® (phentermine and topiramate extended-release) capsules CIV

Qsymia® is an FDA-approved prescription medicine that may help some obese adults or some overweight adults who also have weight-related medical problems lose weight and keep the weight off.  Qsymia should be used with a reduced-calorie diet and increased physical activity.

» For more information on Qsymia, please visit their website


 

Contrave FDA Approved Weight Loss

CONTRAVE CRAVING AND APPETITE SUPPRESSANT PROGRAM

CONTRAVE extended release tablet is a new FDA-approved weight loss drug for obese adults with a Body Mass Index (BMI) of 30 or more, or BMI of 27 or greater with one or more obesity-related medical problems such as high blood pressure or Type-2 diabetes.

It works by unleashing it’s power on the brain to quell cravings in the brain’s highly complex behavior-reward center, and also reduces appetite.  Contrave contains both buproprion and naltrexone. Buprupion is also known as the branded prescription drug Wellbutrin, a quality anti-depressant. Naltrexone is a prescription drug used to treat addiction, in cases such as smoking, alcohol or even opiates. Because of its unique ingredients, Contrave is not for use with certain other prescription drugs, over-the-counter weight loss products, herbal supplements, or heavy alcohol use.

This program includes a personalized reduced-calorie diet, a simple exercise plan, and medically-monitored office visits, which combined with this prescription, will give you the power and control needed to reduce up to 15% of your starting weight.

» For more information on Contrave, please visit their website.

__________________________________________________________________________________________________

-FDA-Approved Injectible Weight Loss Program-

Saxenda helps our patients who may have excess weight, obesity, or other weight-related medical problems.

Saxenda addresses the challenge and other factors associated with taking the weight off and keeping it off. It will give you balance in your body and control in your brain to make the right choices with no side effects.

»For more information on Saxenda, please visit their website. https://www.saxenda.com/